Kengreal (cangrelor) - Chiesi
epinephrine - Generic mfg.
Feasibility of cangrelor-spiked specimens for platelet function proficiency testing across three survey formats (ISTH 2026) - May 25, 2026 - Abstract #PB1235; Pres time: Jul 12, 2026; 01:45 PM - 02:45 PM; Location: Exhibition Hall- Poster Area; "In PF1, 5/7 laboratories returned results; all 5/5 reported abnormal collagen/ADP cartridge closure time (CT) with ≥1 cangrelor concentration, whereas results with the collagen/epinephrine cartridge were more variable. Conclusions Cangrelor-spiked specimens produced consistent ADP-pathway inhibition across three platelet function survey formats, supporting feasibility of incorporating cangrelor as a practical PT challenge for platelet function testing. DOI*10.1016/j.rpth.2026.104097" 
Cardiovascular • Hematological Disorders • Thrombosis
https://distribution.us.m-anage.com/from.storage?image=8MXTD3tiPM0pgLGzC3Lue-GH_h7kZndqGGsHYIgDnOyfvNUFFLURGKSaziet1o790
 
Eric Salazar 1; Vineeta Shivde 2; Jeffrey Dlott 3; Nathan Lickteig 4; Joseph Mulvey 5; Morayma Reyes-Gil 6; Jun Teruya 7; Oksana Volod 8; Nicole Zantek 9; Kristi Smock 10
 
May 25, 2026
 
Prev Next